Edition:
India

Panacea Biotec Ltd (PNCA.NS)

PNCA.NS on National Stock Exchange of India

159.45INR
25 Apr 2017
Change (% chg)

-- (--)
Prev Close
Rs159.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
170,578
52-wk High
Rs178.60
52-wk Low
Rs84.30

PNCA.NS

Chart for PNCA.NS

About

Panacea Biotec Limited is a health management company. The Company's principal business activity is the manufacture of allopathic pharmaceuticals preparations. The Company's segments include Vaccines, Formulations, Research and Development; Healthcare and Real estate activities. Its Vaccines, Formulations and Research &... (more)
No analyst recommendations are available for PNCA.NS.

Overall

Beta: 1.20
Market Cap(Mil.): Rs9,766.43
Shares Outstanding(Mil.): 61.25
Dividend: --
Yield (%): --

Financials

  PNCA.NS Industry Sector
P/E (TTM): -- 29.34 30.35
EPS (TTM): -- -- --
ROI: -- 13.84 13.36
ROE: -- 14.77 14.50

Morning News Call - India, April 24

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_04242017.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 3:45 pm: Farm Minister Radha Mohan Singh at an event in New Delhi. LIVECHAT-COMMODITIES From copper to oil and everything in between, the Gold & Silver Club's Nik Kalsi and Phil Carr wil

24 Apr 2017

Deals of the day-Mergers and acquisitions

April 21 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

22 Apr 2017

Narayana Hrudayalaya to buy NewRise Healthcare

Healthcare services provider Narayana Hrudayalaya Ltd said it would buy NewRise Healthcare Private Ltd from Panacea Biotec Ltd for an enterprise value of 1.80 billion rupees ($27.87 million).

21 Apr 2017

India's Narayana Hrudayalaya to buy NewRise Healthcare

April 21 Indian healthcare services provider Narayana Hrudayalaya Ltd said it would buy NewRise Healthcare Private Ltd from Panacea Biotec Ltd for an enterprise value of 1.80 billion rupees ($27.87 million).

21 Apr 2017

BRIEF-Narayana Hrudayalaya enteres deal to buy Newrise Healthcare

* Says entered deal to buy 100 percent stake in Newrise Healthcare from Panacea Biotec and Panera Biotec

21 Apr 2017

BRIEF-Panacea Biotec launches vaccine, Easysix, for 6 preventable diseases

* Says introduces fully liquid hexavalent combination vaccine easysixtm for six preventable diseases Source text for Eikon: Further company coverage:

29 Mar 2017

BRIEF-Panacea Biotec says it has not signed any definitive agreement with Narayana Hrudayalaya

* Panacea Biotec clarifies on news item "Narayana Hrudayalaya in advanced talks to buy Panacea Biotec's Gurgaon hospital."

01 Mar 2017

BRIEF-Panacea Biotec Dec qtr loss widens

* Dec quarter net loss 292.5 million rupees versus loss 173.8 million rupees year ago

14 Feb 2017

BUZZ-India's Panacea Biotec hits over 1-year high; U.S. FDA okays generic migraine drug

** Drug maker Panacea Biotec Ltd surges as much as 17.4 pct to its highest since Dec 8, 2015

18 Jan 2017

BRIEF-Panacea Biotec gets ANDA approval to market generic version of rizatriptan benzoate tablet

* Panacea Biotec Ltd says ANDA approval for us market and lta & award from un agencies for supply of pentavalent vaccine (easyfive-TT)

18 Jan 2017

More From Around the Web

Earnings vs. Estimates